This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ICL vs. NGVT: Which Stock Is the Better Value Option?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
Ingevity (NGVT) Up 20% in a Year: What's Driving the Stock?
by Zacks Equity Research
Let's take a look into the factors that are working in Ingevity's (NGVT) favor.
ICL or NGVT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
ICL or NGVT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
Why Is Ingevity Corporation (NGVT) Down 13.3% Since Last Earnings Report?
by Zacks Equity Research
Ingevity Corporation (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ICL vs. NGVT: Which Stock Is the Better Value Option?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
Ingevity's (NGVT) Earnings Beat Estimates in Q1, Sales Lag
by Zacks Equity Research
Ingevity (NGVT) gained from the addition of the engineered polymers product line in Q1. The company reaffirmed its guidance for 2019.
Ingevity Corporation (NGVT) Tops Q1 Earnings Estimates
by Zacks Equity Research
Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 4.21% and -0.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
DowDuPont (DWDP) Gears Up for Q1 Earnings: What's in Store?
by Anindya Barman
DowDuPont's (DWDP) Agriculture unit faces challenges from the impact of bad weather conditions in Q1.
What's in Store for Scotts Miracle-Gro (SMG) in Q2 Earnings?
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) fiscal Q2 results to benefit from growth in the Hawthorne segment.
CF Industries (CF) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CF Industries (CF) to benefit from higher demand of nitrogen fertilizers in Q1.
U.S. Steel (X) Warms Up to Q1 Earnings: What's in the Cards?
by Anindya Barman
U.S. Steel (X) will likely witness some pressure on shipment volumes in the first quarter.
Can Arconic (ARNC) Maintain Earnings Beat Streak in Q1?
by Zacks Equity Research
Arconic (ARNC) will likely gain from strong momentum across its major end-markets in Q1.
Can Global Industrial Unit Fuel Ecolab's (ECL) Q1 Earnings?
by Zacks Equity Research
Expected sales growth across segments, product innovation and accelerating pricing are likely to aid Ecolab (ECL) in Q1. However, forex might play spoilsport.
Ingevity Corporation (NGVT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ingevity Corporation (NGVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for LyondellBasell (LYB) in Q1 Earnings?
by Zacks Equity Research
While LyondellBasell (LYB) faces headwinds from maintenance outages and pressure on olefin margins, it should gain from the A. Schulman buyout in Q1.
What's in the Cards for Freeport (FCX) This Earnings Season?
by Zacks Equity Research
Higher unit net cash costs for copper is likely to affect Freeport's (FCX) performance in Q1.
Is a Beat in Store for Cleveland-Cliffs (CLF) in Q1 Earnings?
by Nilanjan Gupta
Cleveland-Cliffs expects (CLF) weak price and tonnage in Q1 results.
Air Products (APD) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Air Products' (APD) Industrial Gases - Americas unit is expected to benefit from higher volumes in Q2 earnings. However, lower activity from the Jazan project is a concern for the Global segment.
What's in Store for Eastman Chemical (EMN) in Q1 Earnings?
by Zacks Equity Research
While Eastman Chemical (EMN) faces input cost pressure, it should gain from productivity actions and growth of high margin products in Q1.
Is a Beat in Store for Sherwin-Williams' (SHW) Q1 Earnings?
by Zacks Equity Research
Sherwin-Williams' (SHW) Q1 results to benefit from cost-control initiatives and synergies of the Valspar acquisition.
Celanese (CE) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not show that Celanese (CE) is likely to beat estimates this quarter.
Nucor (NUE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Lower sheet prices will likely hurt Nucor's (NUE) results in the first quarter.
Will Higher Costs, FX Dent PPG Industries (PPG) Q1 Earnings?
by Zacks Equity Research
Our proven model does not show that PPG Industries (PPG) is likely to beat the Zacks Consensus Estimate this quarter.
Newmont Goldcorp Deal Receives Nod From Investment Canada Act
by Zacks Equity Research
Newmont (NEM) and Goldcorp expect the transaction to close on Apr 18, 2019, which is subject to customary closing conditions.